Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.760
0.00 (0.00%)
At close: Oct 1, 2026, 4:00 PM EDT
3.740
-0.020 (-0.53%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $214.35 million as of October 1, 2026. Its market cap has increased by 139.38% in one year.
Market Cap
214.35M
Enterprise Value
24.37M
1-Year Change
139.38%
Ranking
Category
Stock Price
$3.76
ChartMarket Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $214.35M, a decrease of -60.36%. That is a compound annual growth rate of -16.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 214.35M | 87.95% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yarrow Bioscience | 225.07M |
| Compugen | 222.60M |
| Keros Therapeutics | 221.87M |
| Cartesian Therapeutics | 219.05M |
| Anavex Life Sciences | 218.76M |
| Protalix BioTherapeutics | 216.74M |
| Adagene | 215.53M |
| Foghorn Therapeutics | 209.04M |